Purpose: This study represents a descriptive analysis of preliminary results of a Phase II trial on a novel mixed beam radiotherapy (RT) approach, consisting of carbon ions RT (CIRT) followed by intensity-modulated photon RT, in combination with hormonal therapy, for high-risk prostate cancer (HR PCa) with a special focus on acute toxicity.
Methods: Primary endpoint was the evaluation of safety in terms of acute toxicity. Secondary endpoints were early and long-term tolerability of treatment, quality of life (QoL), and efficacy. Data on acute and late toxicities were collected according to RTOG/EORTC. QoL of enrolled patients was assessed by IPSS, EORTC QLQ-C30, EORTC QLQ-PR25, and sexual activity by IIEF-5.
Results: Twenty-six patients were enrolled in the study, but only 15 completed so far the RT course and were included. Immediately after CIRT, no patients experienced GI/GU toxicity. At 1 and 3 months from the whole course RT completion, no GI/GU toxicities greater than grade 2 were observed. QoL scores were overall satisfactory.
Conclusions: The feasibility of the proposed mixed treatment schedule was assessed, and an excellent acute toxicity profile was recorded. Such findings instil confidence in the continuation of this mixed approach, with evaluation of long-term tolerability and efficacy.
Keywords: carbon-ion radiotherapy; high-risk prostate cancer; intensity modulated radiotherapy; mixed-beam approach; phase II study.
Copyright © 2021 Marvaso, Vischioni, Pepa, Zaffaroni, Volpe, Patti, Bellerba, Gandini, Comi, Corrao, Zerini, Augugliaro, Fodor, Russo, Molinelli, Ciocca, Ricotti, Valvo, Giandini, Avuzzi, Valdagni, De Cobelli, Cattani, Orlandi, Jereczek-Fossa and Orecchia.